Zurück geht es hier Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.
23.04.2025 10:00:00

Elanders AB: Quarterly Report January – March 2025

First quarter 2025

  • Net sales amounted to MSEK 3,232 (3,268), which corresponded to an organic net sales reduction of two percent compared to the same period last year, excluding acquisitions and discontinued operations, and using unchanged exchange rates.
  • Adjusted EBITA amounted to MSEK 133 (180), which equaled an adjusted EBITA margin of 4.1 (5.5) percent.
  • Operating profit was impacted by one-off items of MSEK -87 (-26), which mainly referred to structural measures to meet a weaker market and over time improve the Group’s margins. The structural measures are expected to result in annual cost savings of around MSEK 145, of which around MSEK 81 in 2025.
  • Adjusted net result amounted to MSEK -21 (32), corresponding to SEK -0.60 (0.89) per share.
  • Operating cash flow adjusted for purchase prices for acquisitions amounted to MSEK 520 (641). Operating cash flow including acquisitions amounted to MSEK 503 (121).
  • Cash conversion increased to 138 (137) percent, excluding purchase prices for acquisitions.
  • Free cash flow per share was SEK 10.1 (13.8).
  • Net debt decreased by MSEK 862 to MSEK 8,250 compared to MSEK 9,112 at the beginning of the year. Excluding effects from IFRS 16, net debt decreased by MSEK 345 to MSEK 3,686 compared to MSEK 4,031 at the beginning of the year.
  • During the first quarter the existing credit agreement was extended, which is an important step in ensuring long-term growth and stability.

Further information can be found on Elanders’ website www.elanders.com or requested via e-mail info@elanders.com

Questions concerning this report can be addressed to:

Magnus Nilsson
President and CEO 
Phone: +46 31 750 07 50 

Åsa Vilsson
CFO 
Phone: +46 31 750 07 50  

Elanders AB (publ)  
(Company ID 556008-1621) 
Flöjelbergsgatan 1 C
431 37 Mölndal, Sweden 
Phone: +46 31 750 00 00 

This information is information that Elanders AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 10:00 CET on 23 April 2025. 

Attachment


Analysen zu Elanders ABShs-B-

  • Alle
  • Kaufen
  • Hold
  • Verkaufen
  • ?
Zu diesem Datensatz liegen uns leider keine Daten vor.
Eintrag hinzufügen

Erfolgreich hinzugefügt!. Zu Portfolio/Watchlist wechseln.

Es ist ein Fehler aufgetreten!

Kein Portfolio vorhanden. Bitte zusätzlich den Namen des neuen Portfolios angeben. Keine Watchlisten vorhanden. Bitte zusätzlich den Namen der neuen Watchlist angeben.

CHF
Hinzufügen

3 Knaller-Aktien im BX Musterportfolio📈: Thales, Generali & Swiss Life mit François Bloch

Im BX Morningcall werden folgende Aktien analysiert und erklärt:
📌 Thales Group (FR0000121329)
📌 Assicurazioni Generali (IT0000062072)
📌 Swiss Life Holding (CH0014852781)

➡️ Ausserdem zeigen wir, welche Aktien das Portfolio verlassen haben und warum:
❌ Meta Platforms (US30303M1027)
❌ LPL Financial (US50212V1008)
❌ American Express (US0258161092)

Pünktlich zum Börsenstart diskutieren Investment-Stratege François Bloch und Börsen-Experte David Kunz oder Olivia Hähnel über ausgewählte Top-Aktienwerte aus dem BX Musterportfolio.

👉🏽 https://bxplus.ch/bx-musterportfolio/

3 Knaller-Aktien im BX Musterportfolio📈: Thales, Generali & Swiss Life | Rebalancing im #BXMusterportfolio

Mini-Futures auf SMI

Typ Stop-Loss Hebel Symbol
Short 12’325.26 18.31 B7RS6U
Short 12’564.67 13.42 BKFSAU
Short 13’001.15 8.91 BVKSPU
SMI-Kurs: 12’116.98 30.04.2025 17:30:04
Long 11’640.00 19.68
Long 11’100.00 13.97
Long 10’640.00 7.42
Die Produktdokumentation, d.h. der Prospekt und das Basisinformationsblatt (BIB), sowie Informationen zu Chancen und Risiken, finden Sie unter: https://keyinvest-ch.ubs.com

finanzen.net News

Datum Titel
{{ARTIKEL.NEWS.HEAD.DATUM | date : "HH:mm" }}
{{ARTIKEL.NEWS.BODY.TITEL}}